|
|
|
|
| LEADER |
02239cam a22005174a 4500 |
| 001 |
in00004507336 |
| 005 |
20191204153044.0 |
| 008 |
070223s2007 njua b 001 0 eng |
| 010 |
|
|
|a 2007008032
|
| 015 |
|
|
|a GBA738985
|2 bnb
|
| 016 |
7 |
|
|a 101300038
|2 DNLM
|
| 016 |
7 |
|
|a 013751441
|2 Uk
|
| 020 |
|
|
|a 9780470073735 (cloth : alk. paper)
|
| 020 |
|
|
|a 047007373X (cloth : alk. paper)
|
| 029 |
1 |
|
|a NLM
|b 101300038
|
| 035 |
|
|
|a (OCoLC)ocm85498627
|
| 035 |
|
|
|a (OCoLC)85498627
|
| 035 |
|
|
|z (UtOrBLW)44548
|
| 035 |
|
|
|a 64557
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d BAKER
|d BTCTA
|d UKM
|d C#P
|d YDXCP
|d TMV
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 049 |
|
|
|a TMVM
|c 1
|
| 050 |
0 |
0 |
|a RS189
|b .T85 2007
|
| 060 |
0 |
0 |
|a 2007 I-806
|
| 060 |
1 |
0 |
|a QV 771
|b T948n 2007
|
| 082 |
0 |
0 |
|a 615/.19
|2 22
|
| 100 |
1 |
|
|a Turner, J. Rick.
|
| 245 |
1 |
0 |
|a New drug development :
|b design, methodology, and analysis /
|c J. Rick Turner.
|
| 264 |
|
1 |
|a Hoboken, N.J. :
|b Wiley-Interscience,
|c [2007]
|
| 264 |
|
4 |
|c ©2007
|
| 300 |
|
|
|a xxi, 270 pages :
|b illustrations ;
|c 25 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|b txt
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|b nc
|
| 490 |
1 |
|
|a Statistics in practice
|
| 504 |
|
|
|a Includes bibliographical references (pages [245]-257) and index.
|
| 505 |
0 |
|
|a New drug development -- The regulatory environment for new drug development -- Drug discovery -- Nonclinical research -- Design and methodology in clinical trials -- Statistical analysis -- Statistical significance : employment of hypothesis testing -- Clinical significance : employment of confidence intervals -- Sample-size estimation -- Safety assessment in clinical trials -- Efficacy assessment in clinical trials -- Pharmaceutical and biopharmaceutical drug manufacturing -- Postmarketing surveillance and evidence-based medicine -- Unifying themes and concluding comments.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Pharmacy.
|
| 650 |
|
2 |
|a Clinical Trials as Topic.
|
| 650 |
|
2 |
|a Pharmaceutical Preparations
|x chemical synthesis.
|
| 650 |
|
2 |
|a Drug Industry
|x methods.
|
| 650 |
|
2 |
|a Statistics.
|
| 830 |
|
0 |
|a Statistics in practice.
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 7fe40de0-c516-3fa8-a57e-31533bca7830
|i 34d85f87-3708-331f-9846-b458306cb938
|t 0
|
| 952 |
f |
f |
|p normal
|a Texas A&M University
|b College Station
|c Medical Sciences Library
|d MSL: Book Stacks
|t 0
|e QV 771 T948n 2007
|h National Library of Medicine classification
|i unmediated -- volume
|m 323890195465C
|
| 998 |
f |
f |
|a QV 771 T948n 2007
|t 0
|l MSL: Book Stacks
|